{"data":{"type":"feed_item","id":171811,"entity_id":"wefunder:feed_item:171811","attributes":{"canonical_url":"https://wefunder.com/feed/171811","retrieval_urls":{"canonical":"https://wefunder.com/feed/171811","json":"https://wefunder.com/feed/171811.json","markdown":"https://wefunder.com/feed/171811.md","ai_json":"https://wefunder.com/feed/171811.ai.json","ai_text":"https://wefunder.com/feed/171811.ai.txt","changelog_json":"https://wefunder.com/feed/171811.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2025-07-16T21:27:41.675Z","generated_at":"2026-06-12T23:37:45Z","profile_visibility":"public","feed_item":{"id":171811,"entity_id":"wefunder:feed_item:171811","type":"FeedItem::Update","title":"Progress Update on SJP-002C: Advancing Towards a Breakthrough in Anti-Inflammatory Therapy for Upper Respiratory Infections, including COVID-19 | Sen-Jam Pharmaceutical","content_plain":"Investors, Colleagues, and Friends, We have an update regarding our SJP-002C asset and are excited to share it with you. Frankly Speaking – SJP-002C Update Our Phase 2 clinical trial for SJP-002C, aimed at treating upper respiratory infections inc...","published_at":"2024-03-21T17:16:44.512Z","updated_at":"2025-07-16T21:27:41.675Z","canonical_url":"https://wefunder.com/feed/171811","author":{"name":"Jim Iversen","profile_url":"https://wefunder.com/jimiversen2"},"subject":{"name":"Sen-Jam Pharmaceutical","profile_url":"https://wefunder.com/senjam"}},"provenance":{"source":"wefunder_public_feed_item","last_verified_at":"2025-07-16T21:27:41Z","claims":{"title":{"source":"feed_item.title","last_verified_at":"2025-07-16T21:27:41Z","as_of":"2025-07-16T21:27:41Z","confidence":"high"},"published_at":{"source":"feed_item.published_at","last_verified_at":"2025-07-16T21:27:41Z","as_of":"2024-03-21T17:16:44Z","confidence":"high"}}}}}}